medigraphic.com

2014, Number 2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2014; 52 (2)

Clinical features of acute leukemia and its relationship to the season of the year

Santoyo-Sánchez A, Ramos-Peñafiel C, Palmeros-Morgado G, Mendoza-García E, Olarte-Carrillo I, Martínez-Tovar A, Collazo-Jaloma J

Language: Spanish
References: 30
Page: 176-181
PDF size: 70.68 Kb.


ABSTRACT

Background: In 2009, 17.9 % of hospital morbidity by malignant tumors in México corresponded to hematological malignancies, mainly acute leukemia. Some studies suggest a seasonal pattern, since most of the cases are registered during summer. Our objective was to estimate the relationship between the different subtypes of acute leukemia with the age when the disease arose, and the season of the year.
Methods: Retrospective and observational study, based on records of a hematology department from January 2006 to April 2012. Only the patients diagnosed with de novo acute leukemia, stratifi ed according to the French-American-British classifi cation, were included. Seasonal analysis was performed using Edward’s periodic model.
Results: The study included 833 acute leukemia cases: 48 % of women (400), and 52 % of men (433). Median age was 36.2 ± 19.8 years. Acute lymphoblastic leukemia predominated over acute myeloblastic leukemia subtype M4 (p ‹, 0.05), and we found differences (p ‹ 0.01) between lymphoblastic and myeloblastic leukemias: 32.3 and 41.8. Despite the existence of pronounced peaks in the time series, they did not repeat periodically.
Conclusions: The most common variety of acute leukemia was lymphoblastic type L2, followed by myeloblastic type M4. People over 40 years of age were the most affected. A seasonal pattern of acute leukemias was not observed.


REFERENCES

  1. Ferlay J, Shin HR, Bray F, Forman D, Matehrs C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917.

  2. Tirado-Gómez LL, Mohar-Betancourt A. Epidemiología de las neoplasias hemato-oncológicas. Cancerología. Rev Inst Nal Cancerol Mex. 2007;2(2):109-20.

  3. Pérez-Saldívar ML, Fajardo-Gutiérrez A, Bernáldez- Ríos R, Martínez-Ávalos A, Medina-Sanson A, Espinosa- Hernández L, et al. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer. 2011 Aug 17;11:355.

  4. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukemia. Lancet. 2013;381(9881):1943-55.

  5. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010;36(4):277-85.

  6. Wu XC, Chen VW, Steele B, Roffers S, Klotz JB, Correa CN, et al. Cancer incidence in adolescents and young adults in the United States, 1992-1997. J Adolesc Health. 2003;32(6):405-15.

  7. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al. editores. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) [Internet], Bethesda, MD: National Cancer Institute; 2012. Disponible en http://seer.cancer.gov/ csr/1975_2009_pops09/

  8. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van’t Veer MB. Proposals for the immunological classifi cation of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9(10):1783-6.

  9. Harani MS, Adil SN, Shaikh MU, Kakepoto GN, Khurshid M. Frequency of FAB subtypes in acute myeloid leukemia patients at Aga Khan University Hospital Karachi. J Ayub Med Coll Abbottabad. 2005;17(1):26-9.

  10. Udayakumar AM, Pathare AV, Al-Kindi S, Khan H, Rehmen JU, Zia F, et al. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia. Cancer Genet Cytogenet. 2007;177(2):89-94.

  11. Buitrón-Santiago N, Arteaga-Ortiz L, Rosas-López A, Aguayo A, López-Karpovitch X, Crespo-Solís E. Experiencia del INCMNSZ en pacientes adultos con leucemia mieloide aguda. Cohorte 2003-2008. Rev Invest Clin. 2010;62(2):100-8.

  12. Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control. 2008;19(4):379-90.

  13. Ribeiro RC, Rego E. Management of APL in developing countries: epidemiology, challenges and opportunities for international collaboration. Hematology Am Soc Hematol Educ Program. 2006:162-8.

  14. Otero JC, Santillana S, Fereyros G. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood. 1996;88(1):377.

  15. Brookhart MA, Rothman KJ. Simple estimators of the intensity of seasonal occurrence. BMC Med Res Methodol. 2008 Oct 22;8:67.

  16. Lee JAH. Seasonal variation in leukaemia incidence. Br Med J. 1963;2(5357):623.

  17. Nyári TA, Kajtár P, Parker L. Seasonality of birth and acute lymphoblastic leukemia. J Perinat Med. 2006;34(6):507-8.

  18. Basta NO, James PW, Craft AW, McNally RJ. Season of birth and diagnosis for childhood cancer in Northern England, 1968-2005. Paediatr Perinat Epidemiol. 2010;24(3):309-18.

  19. Van Laar M, Kinsey SE, Picton SV, Feltbower RG. First description of seasonality of birth and diagnosis amongst teenagers and young adults with cancer aged 15-24 years in England, 1996-2005. BMC Cancer. 2013 Jul 31;13:365.

  20. Crespo-Solís E. Epidemiología de las leucemias agudas. Rev Hematologia 2010;11(Supl 1):37-9.

  21. Arteaga-Ortiz L, Buitrón-Santiago N, Rosas-López A, Rosas-Arzate G, Armengol-Jiménez A, Aguayo A, et al. Experiencia del INCMNSZ en pacientes adultos con leucemia linfoide aguda. Cohorte 2003- 2007 con esquemas de tratamiento Hiper-CVAD y Protocolo 0195. Rev Invest Clin. 2008;60(6):459-69.

  22. Hoelzer D, Thiel E, Löffl er H, Büchner T, Ganser A, Heil G, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 1988;71(1):123-31.

  23. Sobrevilla-Calvo P, Acosta-Barreda A, López-Karpóvitch X, Salles-Manuel MT, Reynoso-Gómez E, Guarner-Lans J. Respuesta al tratamiento y supervivencia de adultos con leucemia aguda clasifi cados mediante inmunofenotipo y citoquímica. Rev Invest Clin. 1994;46(5):399-406.

  24. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166-78.

  25. Xie Y, Davies SM, Xiang Y, Robison LL, Ross JA. Trends in leukemia incidence and survival in the United States (1973-1998). Cancer. 2003;97(9):2229-35.

  26. Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I, Jaeger U, Lechner K, Schneider B, et al. The immunophenotype of 325 adult acute leukemias: Relationship to morphologic and molecular classifi cation and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol. 2002;117(3):380-9.

  27. Callera F, Mulin CC, Rosa ES, Melo DB, Melo CM. High prevalence of morphological subtype FAB M1 in adults with de novo acute myeloid leukemia in São José dos Campos, São Paulo. Sao Paulo Med J. 2006;124(1):45-7.

  28. Rego MF, Pinheiro GS, Metze K, Lorand-Metze I. Acute leukemias in Piauí: comparison with features observed in other regions of Brazil. Braz J Med Biol Res. 2003;36(3):331-7.

  29. Gao F, Chia KS, Machin D. On the evidence for seasonal variation in the onset of acute lymphoblastic leukemia (ALL). Leuk Res. 2007;31(10):1327-38.

  30. Calip GS, McDougall JA, Wheldon MC, Li CI, De Roos AJ. Evaluation of seasonality in the diagnosis of acute myeloid leukaemia among adults in the United States, 1992-2008. Br J Haematol. 2013;160(3):343-50.




2020     |     www.medigraphic.com